Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2012, Article ID 609148, 12 pages
http://dx.doi.org/10.1155/2012/609148
Research Article

Selection of a MCF-7 Breast Cancer Cell Subpopulation with High Sensitivity to IL-1β: Characterization of and Correlation between Morphological and Molecular Changes Leading to Increased Invasiveness

1Department of Molecular Biomedicine, Center for Research and Advanced Studies of the National Polytechnic Institute, 2508 Instituto Politecnico Nacional Avenue, 07360 Mexico City, Mexico
2Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute, 2508 Instituto Politecnico Nacional Avenue, 07360 Mexico City, Mexico

Received 10 January 2012; Accepted 26 February 2012

Academic Editor: Robert-Alain Toillon

Copyright © 2012 Eloy Andres Pérez-Yépez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Kalluri and R. A. Weinberg, “The basics of epithelial-mesenchymal transition,” Journal of Clinical Investigation, vol. 119, no. 6, pp. 1420–1428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. P. Their, “Epithelial-mesenchymal transitions in tumor progression,” Nature Reviews Cancer, vol. 2, no. 6, pp. 442–454, 2002. View at Google Scholar · View at Scopus
  3. C. P. Prasad, G. Rath, S. Mathur, D. Bhatnagar, R. Parshad, and R. Ralhan, “Expression analysis of E-cadherin, Slug and GSK3β in invasive ductal carcinoma of breast,” BMC Cancer, vol. 9, article 325, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. F. Logullo, S. Nonogaki, F. S. Pasini, C. A. Osorio, F. A. Soares, and M. M. Brentani, “Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression,” Oncology Reports, vol. 23, pp. 313–320, 2010. View at Google Scholar
  5. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. N. Apte, S. Dotan, M. Elkabets et al., “The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions,” Cancer and Metastasis Reviews, vol. 25, no. 3, pp. 387–408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Germano, P. Allavena, and A. Mantovani, “Cytokines as a key component of cancer-related inflammation,” Cytokine, vol. 43, no. 3, pp. 374–379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Franco-Barraza, J. E. Valdivia-Silva, H. Zamudio-Meza et al., “Actin cytoskeleton participation in the Onset of IL-1β induction of an invasive mesenchymal-like phenotype in epithelial MCF-7 Cells,” Archives of Medical Research, vol. 41, no. 3, pp. 170–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Valdivia-Silva, J. Franco-Barraza, A. L. E. Silva et al., “Effect of pro-inflammatory cytokine stimulation on human breast cancer: implications of chemokine receptor expression in cancer metastasis,” Cancer Letters, vol. 283, no. 2, pp. 176–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. F. M. Wang, H. Q. Liu, S. R. Liu, S. P. Tang, L. Yang, and G. S. Feng, “SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1βin vivo and in vitro,” Breast Cancer Research and Treatment, vol. 89, no. 1, pp. 5–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Conacci-Sorrell, I. Simcha, T. Ben-Yedidia, J. Blechman, P. Savagner, and A. Ben-Ze'ev, “Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of β-catenin signaling, Slug, and MAPK,” Journal of Cell Biology, vol. 163, no. 4, pp. 847–857, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Min-A, S. Kyung-Sook, H. K. Jung et al., “HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium,” Journal of the American Society of Nephrology, vol. 20, no. 3, pp. 567–581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. J. Lee and H. J. Han, “Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells,” American Journal of Physiology, vol. 298, no. 5, pp. F1263–F1275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Martinez-Orozco, N. Navarro-Tito, A. Soto-Guzman, L. Castro-Sanchez, and E. P. Salazar, “Arachidonic acid promotes epithelial-to-mesenchymal-like transition in mammary epithelial cells MCF10A,” European Journal of Cell Biology, vol. 89, no. 6, pp. 476–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. T. Nieman, R. S. Prudoff, K. R. Johnson, and M. J. Wheelock, “N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression,” Journal of Cell Biology, vol. 147, no. 3, pp. 631–644, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Z. Dewan, S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi, and N. Yamamoto, “Stromal cell-derived factor-1 andCXCR4 receptor interaction intumor growth andmetastasis ofbreast cancer,” Biomedicine and Pharmacotherapy, vol. 60, no. 6, pp. 273–276, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Muller, B. Homey, H. Soto et al., “Involvement of chemokine receptors in breast cancer metastasis,” Nature, vol. 410, no. 6824, pp. 50–56, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. C. K. Osborne, K. Hobbs, and J. M. Trent, “Biological differences among MCF-7 human breast cancer cell lines from different laboratories,” Breast Cancer Research and Treatment, vol. 9, no. 2, pp. 111–121, 1987. View at Google Scholar · View at Scopus
  19. J. E. Sims, M. A. Gayle, J. L. Slack et al., “Interleukin 1 signaling occurs exclusively via the type I receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 13, pp. 6155–6159, 1993. View at Google Scholar · View at Scopus
  20. D. Boraschi, P. Bossu, G. Macchia, P. Ruggiero, and A. Tagliabue, “Structure-function relationship in the IL-1 family,” Frontiers in Bioscience, vol. 1, pp. d270–d308, 1996. View at Google Scholar · View at Scopus
  21. K. Matsushima, J. Yodoi, Y. Tagaya, and J. J. Oppenheim, “Down-regulation of interleukin 1 (IL-1) receptor expression by IL-1 and fate of internalized 125I-labeled IL-1β in a human large granular lymphocyte cell line,” Journal of Immunology, vol. 137, no. 10, pp. 3183–3188, 1986. View at Google Scholar · View at Scopus
  22. C. L. Sommers, S. W. Byers, E. W. Thompson, J. A. Torri, and E. P. Gelmann, “Differentiation state and invasiveness of human breast cancer cell lines,” Breast Cancer Research and Treatment, vol. 31, no. 2-3, pp. 325–335, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. E. A. Perez-Yepez, J. T. Ayala-Sumuano, and I Meza, “Enrichment of IL-1β highly responsive MCF-7 cell subpopulations: a method to assess the onset of an epithelial phenotype transition,” in Proceedings of the Cell Signaling Networks, Merida, Mexico, 2011.
  24. K. Gravdal, O. J. Halvorsen, S. A. Haukaas, and L. A. Akslen, “A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer,” Clinical Cancer Research, vol. 13, no. 23, pp. 7003–7011, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. L. Sommers, E. W. Thompson, J. A. Torri, R. Kemler, E. P. Gelmann, and S. W. Byers, “Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities,” Cell Growth & Differentiation, vol. 2, no. 8, pp. 365–372, 1991. View at Google Scholar · View at Scopus
  26. S. Sethi, F. H. Sarkar, Q. Ahmed et al., “Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma,” Translational Oncology, vol. 4, no. 4, pp. 222–226, 2011. View at Google Scholar · View at Scopus
  27. M. Yilmaz and G. Christofori, “EMT, the cytoskeleton, and cancer cell invasion,” Cancer and Metastasis Reviews, vol. 28, no. 1-2, pp. 15–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Vargo-Gogola and J. M. Rosen, “Modelling breast cancer: one size does not fit all,” Nature Reviews Cancer, vol. 7, no. 9, pp. 659–672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Lacroix and G. Leclercq, “Relevance of breast cancer cell lines as models for breast tumours: an update,” Breast Cancer Research and Treatment, vol. 83, no. 3, pp. 249–289, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. E. Burdall, A. M. Hanby, M. R. Lansdown, and V. Speirs, “Breast cancer cell lines: friend or foe?” Breast Cancer Research, vol. 5, no. 2, pp. 89–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Uchino, H. Kojima, K. Wada et al., “Nuclear β-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells,” BMC Cancer, vol. 10, article 414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Jin, R. Q. Yuan, A. Fuchs et al., “Expression of interleukin-1ß in human breast carcinoma,” Cancer, vol. 80, pp. 421–434, 1997. View at Google Scholar
  33. X. Lu and Y. Kang, “Organotropism of breast cancer metastasis,” Journal of Mammary Gland Biology and Neoplasia, vol. 12, no. 2-3, pp. 153–162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Mohammadizadeh, H. Ghasemibasir, P. Rajabi, A. Naimi, A. Eftekhari, and A. Mesbah, “Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma,” Cancer Biomarkers, vol. 5, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Mareel and S. Constantino, “Ecosystems of invasion and metastasis in mammary morphogenesis and cancer,” The International Journal of Developmental Biology, vol. 55, pp. 671–684, 2011. View at Google Scholar
  36. A. Soto-Guzman, N. Navarro-Tito, L. Castro-Sanchez, R. Martinez-Orozco, and E. P. Salazar, “Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells,” Clinical and Experimental Metastasis, vol. 27, no. 7, pp. 505–515, 2010. View at Publisher · View at Google Scholar · View at Scopus